What’s new in minimal residual disease (MRD) detection in myeloma?
Open questions in the use of imaging techniques for assessing response in multiple myeloma
Key abstracts being presented at ASH 2017
New antibody treatments for AL amyloidosis
Challenges in MM guideline implementation